Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

Christine Rasetti-EscargueilDivision of Bacteriology; National Institute for Biological Standards and Control (NIBSC), a centre of Medicines and Healthcare products Regulatory Agency; HertfordshireUK

Arnaud AvrilDépartement des Maladies Infectieuses; Unité Interaction Hôte-Pathogène; Institut de Recherche Biomédicale des Armées (IRBA); Brétigny-sur-Orge, France

Siham ChahbounDépartement des Maladies Infectieuses; Unité Interaction Hôte-Pathogène; Institut de Recherche Biomédicale des Armées (IRBA); Brétigny-sur-Orge, France

Rob TierneyDivision of Bacteriology; National Institute for Biological Standards and Control (NIBSC), a centre of Medicines and Healthcare products Regulatory Agency; HertfordshireUK

Nicola BakDivision of Bacteriology; National Institute for Biological Standards and Control (NIBSC), a centre of Medicines and Healthcare products Regulatory Agency; HertfordshireUK

Sebastian MietheInstitut für Biochemie, Biotechnologie und Bioinformatik; Technische Universität Braunschweig; Braunschweig, Germany

Christelle MazuetUnité des Bactéries anaérobies et Toxines; Institut Pasteur; Paris, France

Michel R PopoffUnité des Bactéries anaérobies et Toxines; Institut Pasteur; Paris, France

Philippe ThullierDépartement des Maladies Infectieuses; Unité Interaction Hôte-Pathogène; Institut de Recherche Biomédicale des Armées (IRBA); Brétigny-sur-Orge, France

Michael HustInstitut für Biochemie, Biotechnologie und Bioinformatik; Technische Universität Braunschweig; Braunschweig, Germany

Thibaut PelatDépartement des Maladies Infectieuses; Unité Interaction Hôte-Pathogène; Institut de Recherche Biomédicale des Armées (IRBA); Brétigny-sur-Orge, France

Dorothea SesardicDivision of Bacteriology; National Institute for Biological Standards and Control (NIBSC), a centre of Medicines and Healthcare products Regulatory Agency; HertfordshireUKCorrespondence[email protected]

show all

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

Supplemental_Material.zip

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B

Supplemental_Material.zip

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date